Lv3
206 积分 2024-09-21 加入
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
8天前
已完结
Patient-Derived Bladder Cancer Organoids: Model Construction and Drug Sensitivity Testing
1个月前
已完结
Algorithmic assessment of cellular senescence in experimental and clinical specimens
2个月前
已完结
L1 drives IFN in senescent cells and promotes age-associated inflammation
2个月前
已完结
Nanoparticle Delivery of MnO2 and Antiangiogenic Therapy to Overcome Hypoxia-Driven Tumor Escape and Suppress Hepatocellular Carcinoma
2个月前
已完结
Profiling of syngeneic mouse HCC tumor models as a framework to understand anti–PD‐1 sensitive tumor microenvironments
3个月前
已完结
Antiangiogenic Treatment Facilitates the Abscopal Effect of Radiation Therapy Combined With Anti-PD-1 in Hepatocellular Carcinoma
3个月前
已完结
Sorafenib response in hepatocellular carcinoma: MicroRNAs as tuning forks
4个月前
已完结
The frontal cortex as a network hub controlling mood and cognition: Probing its neurochemical substrates for improved therapy of psychiatric and neurological disorders
4个月前
已完结
Senolysis Enabled by Senescent Cell‐Sensitive Bioorthogonal Tetrazine Ligation
7个月前
已完结
皖公网安备34019202002308
